Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Market Analysis & Valuation

UpdatedFeb 10, 2026
DataAggregated Company Financials
Companies1093
  • 7D0.5%
  • 3M5.9%
  • 1Y19.3%
  • YTD5.0%

Over the last 7 days, the market has remained flat, although notably the Materials sector gained 3.2% in that time. Meanwhile, the market is actually up 19% over the past year. Earnings are forecast to grow by 14% annually.

Trending IndustriesOil and GasGoldBiotechSoftware

Market Valuation and Performance

Has the U.K. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 10 Feb 2026UK£3.0tUK£1.9tUK£140.4b16.8x21.2x1.5x
Thu, 08 Jan 2026UK£2.9tUK£2.0tUK£137.8b16.6x20.9x1.5x
Sat, 06 Dec 2025UK£2.8tUK£2.0tUK£139.2b16x20x1.4x
Mon, 03 Nov 2025UK£2.8tUK£2.0tUK£138.8b16.5x20.1x1.4x
Wed, 01 Oct 2025UK£2.7tUK£1.9tUK£135.7b16.6x19.9x1.4x
Fri, 29 Aug 2025UK£2.7tUK£1.9tUK£135.3b15.9x19.7x1.4x
Sun, 27 Jul 2025UK£2.6tUK£1.9tUK£125.2b16.4x20.5x1.3x
Tue, 24 Jun 2025UK£2.5tUK£1.9tUK£127.2b16.4x19.5x1.3x
Thu, 22 May 2025UK£2.5tUK£2.0tUK£127.2b16.4x19.7x1.3x
Sat, 19 Apr 2025UK£2.4tUK£2.0tUK£134.9b15.3x17.5x1.2x
Mon, 17 Mar 2025UK£2.5tUK£2.0tUK£137.0b15x18.1x1.2x
Wed, 12 Feb 2025UK£2.5tUK£2.0tUK£123.9b16.1x20.5x1.2x
Fri, 10 Jan 2025UK£2.4tUK£2.1tUK£124.2b15.8x19.6x1.2x
Sun, 08 Dec 2024UK£2.4tUK£2.0tUK£122.3b16.5x20x1.2x
Tue, 05 Nov 2024UK£2.4tUK£2.0tUK£114.9b16.3x21x1.2x
Thu, 03 Oct 2024UK£2.4tUK£2.0tUK£117.8b16.6x20.6x1.2x
Sat, 31 Aug 2024UK£2.5tUK£2.0tUK£119.2b16.9x20.7x1.2x
Mon, 29 Jul 2024UK£2.4tUK£2.0tUK£127.1b16.5x19.2x1.2x
Wed, 26 Jun 2024UK£2.4tUK£2.0tUK£131.8b16.4x18.4x1.2x
Fri, 24 May 2024UK£2.5tUK£2.0tUK£127.0b17.2x19.6x1.2x
Sun, 21 Apr 2024UK£2.4tUK£2.1tUK£148.4b15.6x16.1x1.1x
Tue, 19 Mar 2024UK£2.3tUK£2.1tUK£145.0b15.9x16x1.1x
Thu, 15 Feb 2024UK£2.3tUK£2.0tUK£144.4b15.1x15.6x1.1x
Sat, 13 Jan 2024UK£2.3tUK£2.1tUK£193.4b14.9x12x1.1x
Mon, 11 Dec 2023UK£2.3tUK£2.1tUK£194.1b14.6x11.8x1.1x
Wed, 08 Nov 2023UK£2.2tUK£2.2tUK£194.5b13.8x11.5x1x
Fri, 06 Oct 2023UK£2.3tUK£2.2tUK£187.0b14.1x12.2x1x
Sun, 03 Sep 2023UK£2.3tUK£2.2tUK£184.9b14.5x12.5x1.1x
Tue, 01 Aug 2023UK£2.4tUK£2.2tUK£194.0b14.6x12.3x1.1x
Thu, 29 Jun 2023UK£2.3tUK£2.2tUK£209.2b14.2x11.1x1.1x
Sat, 27 May 2023UK£2.4tUK£2.2tUK£214.0b14x11.2x1.1x
Mon, 24 Apr 2023UK£2.5tUK£2.2tUK£178.7b14.1x13.9x1.1x
Wed, 22 Mar 2023UK£2.3tUK£2.2tUK£182.7b13.7x12.6x1.1x
Fri, 17 Feb 2023UK£2.6tUK£2.2tUK£202.9b13.8x12.7x1.2x
Price to Earnings Ratio

12.7x


Total Market Cap: UK£2.6tTotal Earnings: UK£202.9bTotal Revenue: UK£2.2tTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Market Price to Earnings3Y Average 16.9x202420252026
Current Market PE
  • Investors are optimistic on the British market, and appear confident in strong long term growth rates.
  • The market is trading at a PE ratio of 21.2x which is higher than its 3-year average PE of 16.9x.
Past Earnings Growth
  • The earnings for companies in the British industry have declined 12% per year over the last three years.
  • Revenues have also declined 3.6% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Sector Trends

Which sectors have driven the changes within the U.K. Market?

GB Market0.53%
Materials3.21%
Consumer Staples2.96%
Utilities2.60%
Energy2.34%
Healthcare2.20%
Telecom-0.18%
Industrials-0.34%
Real Estate-0.90%
Financials-1.90%
Consumer Discretionary-3.23%
Tech-5.47%
Sector PE
  • Investors favour the Materials sector the most for future growth, which is trading above its 3-year average PE ratio of 20.2x.
    • Analysts expect its future annual earnings growth (31.3%) to be largely in line with prior year's earnings growth.
    • The market's confidence could indicate that the market believes that analysts are underestimating future growth.
Forecasted Growth
  • Analysts are most optimistic on the Materials sector, expecting annual earnings growth of 31% over the next 5 years.
  • This is roughly in line with its past earnings growth rate.
  • In contrast, the Industrials sector is expected to see its earnings grow by 7.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
GSK GSKUK£21.5912.2%
+UK£9.4b		47.3%PE15.2xHealthcare
ULVR UnileverUK£51.653.5%
+UK£4.0b		-2.5%PE23.7xConsumer Staples
RR. Rolls-Royce HoldingsUK£12.753.6%
+UK£3.7b		107.9%PE18.4xIndustrials
SHEL ShellUK£28.231.6%
+UK£2.4b		7.0%PE12.3xEnergy
BP. BPUK£4.783.4%
+UK£2.4b		2.7%PE66.1xEnergy
See more

Market Insights

Header cover image
Why alternative investments are making a splash 🖼️
Richard Bowman avatar
Richard Bowman
|
|
Is it the time to invest in alternatives? Here's how you can get exposure.
Continue reading
Why longer lifespans could reshape portfolios 🧓
Last Week

Why longer lifespans could reshape portfolios 🧓

Latest News

EXPN
UK£25.01
Experian
7D
-8.7%
1Y
-36.7%
NWG
UK£6.20
NatWest Group
7D
-9.4%
1Y
40.5%
CPG
UK£20.81
Compass Group
7D
-7.4%
1Y
-24.4%

CPG: Premium P/E And Dividend Framework Will Support Long Runway

Narrative Update The updated analyst price target for Compass Group shifts modestly to £28.19 from £28.33, as analysts balance mixed recent price target moves with slight adjustments to growth, margin, and P/E assumptions in their models. Analyst Commentary Recent research updates on Compass Group give you a mixed but useful read on how the Street is thinking about the shares, with one increase and one reduction in price targets feeding into the modest change in the overall average target.
SHEL
UK£28.23
Shell
7D
1.6%
1Y
7.0%
RR.
UK£12.75
Rolls-Royce Holdings
7D
3.6%
1Y
107.9%
GSK
UK£21.59
GSK
7D
12.2%
1Y
47.3%
BARC
UK£4.87
Barclays
7D
-2.6%
1Y
60.7%
BP.
UK£4.78
BP
7D
3.4%
1Y
2.7%

BP.: Future Returns Will Balance Portfolio Sales Softer Crude And Leadership Change

Analysts have trimmed their BP price targets by a few dollars or pence overall, reflecting slightly lower fair value estimates and revenue growth assumptions. This has been partially offset by a small uplift in expected profit margins and future P/E, as firms reassess the company around a softer crude outlook, refining tailwinds, and an upcoming CEO transition.
SGE
UK£8.41
Sage Group
7D
-12.9%
1Y
-36.4%
ULVR
UK£51.65
Unilever
7D
3.5%
1Y
-2.5%

ULVR: Margin And U.S. Slowdown Concerns Will Keep Shares Subdued

Analysts have made a small trim to their Unilever fair value estimate to about €40.87 per share, reflecting slightly higher assumed future P/E, a modestly lower discount rate, and mixed sector views that now include a downgrade to Neutral and a cautious stance on valuation, despite a higher Jefferies price target to £41.00. Analyst Commentary Recent research points to a cautious tone around Unilever, with several bearish analysts focusing on valuation, earnings visibility, and execution risks over the next couple of years.
DGE
UK£17.56
Diageo
7D
5.2%
1Y
-20.1%

DGE: Premium Portfolio And Cost Discipline Will Benefit From Expected Consumer Tailwinds

Narrative Update on Diageo Analysts have trimmed their Diageo fair value estimate slightly, by about $0.23 to $20.57, reflecting more muted assumptions for revenue growth and profit margins, partly offset by a modestly higher future P/E multiple. Analyst Commentary Recent Street research around consumer and value-focused retailers gives some context for how analysts are thinking about companies with everyday spending exposure, which can be useful when you think about Diageo.
NG.
UK£12.86
National Grid
7D
3.7%
1Y
31.6%

Estimating The Intrinsic Value Of National Grid plc (LON:NG.)

Feb 04
Estimating The Intrinsic Value Of National Grid plc (LON:NG.)
REL
UK£21.33
RELX
7D
-17.5%
1Y
-47.7%
AZN
UK£138.88
AstraZeneca
7D
-1.1%
1Y
18.5%

AZN: Oncology Pipeline And Manufacturing Investments Will Shape Balanced Long-Term Outlook

Analysts have lifted their AstraZeneca fair value estimate to £152.79 from £150.26, reflecting higher price targets from several firms and updated views on the company’s revenue growth, profit margins and future P/E assumptions. Analyst Commentary Recent Street research on AstraZeneca has been active, with several bullish analysts lifting price targets and initiating positive coverage.
HSBA
UK£13.19
HSBC Holdings
7D
1.1%
1Y
52.3%

HSBA: Future Returns Will Hinge On Chair Succession Rather Than Execution

Analysts have nudged their fair value estimate for HSBC Holdings higher to £11.54 from £11.25, citing updated assumptions for slightly faster revenue growth, a modestly higher profit margin, and a P/E multiple that lines up with recent price target moves and rating changes from Citi, Erste Group, and Morgan Stanley. Analyst Commentary Recent Street research on HSBC Holdings points to a mix of optimism around execution in the next few years and some caution on how much of that is already reflected in the share price.
LLOY
UK£1.05
Lloyds Banking Group
7D
-5.6%
1Y
67.6%

LLOY: Buybacks And Dividend Policy Will Support Measured Future Return Profile

Analysts have lifted their price target for Lloyds Banking Group to £1.08 from £0.96, citing adjusted assumptions for revenue growth, profit margins and future P/E multiples that point to a higher assessed fair value. What's in the News The Board of Directors has authorized a new share buyback plan, approved on 30 January 2026.